NCT01324336View on ClinicalTrials.gov

Comparative Pharmacokinetics of a Compounded 6-mercaptopurine Liquid Formulation Preparation and Tablets

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Acute Lymphoblastic Leukemia
Interventions
DRUG

6-Mercaptopurine

75 mg/m2/dose/day

Trial Locations (1)

64108

The Children's Mercy Hospital, Kansas City

All Listed Sponsors
collaborator

Midwest Cancer Alliance

UNKNOWN

lead

Children's Mercy Hospital Kansas City

OTHER

NCT01324336 - Comparative Pharmacokinetics of a Compounded 6-mercaptopurine Liquid Formulation Preparation and Tablets | Biotech Hunter | Biotech Hunter